Valuation: Beijing Airdoc Technology Co., Ltd.

Market Cap 930M 1.08B 137M 120M 111M 102M 194M 13.08B 197M 1.32B 519M 6.44B 515M 504M 22.16B P/E 2026 *
-24.6x
P/E 2027 * -456x
Enterprise Value 930M 1.08B 137M 120M 111M 102M 194M 13.08B 197M 1.32B 519M 6.44B 515M 504M 22.16B EV / Sales 2026 *
3.69x
EV / Sales 2027 * -
Free-Float
18.88%
Yield 2026 *
-
Yield 2027 * -
1 day-1.03%
1 week-3.83%
Current month-4.87%
1 month-9.61%
3 months-4.18%
6 months-15.68%
Current year-7.79%
1 week 10.21
Extreme 10.21
11.2
1 month 10.21
Extreme 10.21
12
Current year 9.81
Extreme 9.81
13.77
1 year 9.81
Extreme 9.81
16
3 years 7.88
Extreme 7.88
18.38
5 years 7.88
Extreme 7.88
74.95
10 years 7.88
Extreme 7.88
74.95
Manager TitleAgeSince
Chief Executive Officer 43 2015-09-08
General Counsel - 2021-02-28
Corporate Secretary - 2022-01-18
Director TitleAgeSince
Director/Board Member 45 2024-09-19
Chairman 43 2015-09-08
Director/Board Member 51 2022-05-18
Date Insider Type Main position Quantity % Market Cap.
05-28Other

Chief Executive Officer

-165,400 0.1597%
01-19Other

Chief Executive Officer

418,500 0.4041%
25-09-23Other

Chief Executive Officer

35,000 0.0338%
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%-3.83%-16.88%-2.77% 139M
-0.56%-0.98%-32.49%-4.86% 30.82B
-6.34%-4.30%-37.37%+213.11% 15.26B
-0.77%-4.53%-20.85%+62.11% 5.68B
-3.61%-1.40% - - 2.39B
-1.65%-0.88%+50.62%-38.01% 2.07B
-7.25%-13.18% - - 2.02B
-0.98%-12.26%-30.95% - 1.1B
-4.67%-3.52%+46.19%+112.17% 1.02B
+0.60%+0.69%-33.62%+306.25% 825M
Average -2.45%-1.47%-9.42%+92.57% 6.13B
Weighted average by Cap. -2.00%-0.78%-28.16%+67.07%

Financials

2026 *2027 *
Net sales 252M 291M 37.17M 32.51M 29.99M 27.69M 52.55M 3.54B 53.43M 358M 141M 1.75B 140M 137M 6B -
Net income -39M -45.09M -5.75M -5.03M -4.64M -4.29M -8.13M -549M -8.27M -55.45M -21.77M -270M -21.6M -21.13M -929M -
Net Debt - -
Logo Beijing Airdoc Technology Co., Ltd.
Beijing Airdoc Technology Co Ltd is a China-based company primarily engaged in providing artificial intelligence (AI)-empowered retina-based early detection, diagnosis and health risk assessment solutions. The Company’s main products include Myopia Prevention and Control AI (PBM-AI), Retinal Detection AI (Retina AI) and Stress Resilience Monitoring AI (Neuro-AI). The Company offers health risk assessment solutions with the ability to detect risk indicators, including risk assessments of retinal abnormalities, retinal vascular diseases, vitreous abnormalities, retinal tumors, optic nerve pathologies, macular diseases, congenital anomalies of the retina, cardiovascular disease and anemia. The Company conducts its business in the domestic and overseas markets.
Employees
181
Date Price Change Volume
26-07-10 HK$10.54 -1.03% 53,400
26-07-09 HK$10.65 +1.43% 51,900
26-07-08 HK$10.50 -4.89% 87,200
26-07-07 HK$11.04 -0.45% 68,500
26-07-06 HK$11.09 +1.19% 47,100
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
9.115CNY
Average target price
11.22CNY
Spread / Average Target
+23.08%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2251 Stock